nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.034	0.0382	CcSEcCtD
Bicalutamide—CYP2C19—urine—nephrolithiasis	0.0257	0.234	CbGeAlD
Bicalutamide—CYP2C9—urine—nephrolithiasis	0.02	0.181	CbGeAlD
Bicalutamide—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0199	0.0224	CcSEcCtD
Bicalutamide—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.0193	0.0217	CcSEcCtD
Bicalutamide—Gout—Hydrochlorothiazide—nephrolithiasis	0.0192	0.0215	CcSEcCtD
Bicalutamide—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0212	CcSEcCtD
Bicalutamide—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0187	0.021	CcSEcCtD
Bicalutamide—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0169	0.019	CcSEcCtD
Bicalutamide—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0162	0.0182	CcSEcCtD
Bicalutamide—CYP3A4—urine—nephrolithiasis	0.0152	0.138	CbGeAlD
Bicalutamide—CYP2D6—urine—nephrolithiasis	0.015	0.136	CbGeAlD
Bicalutamide—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0168	CcSEcCtD
Bicalutamide—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.014	0.0157	CcSEcCtD
Bicalutamide—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0156	CcSEcCtD
Bicalutamide—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0155	CcSEcCtD
Bicalutamide—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0154	CcSEcCtD
Bicalutamide—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0134	0.015	CcSEcCtD
Bicalutamide—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0145	CcSEcCtD
Bicalutamide—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0141	CcSEcCtD
Bicalutamide—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0137	CcSEcCtD
Bicalutamide—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.012	0.0135	CcSEcCtD
Bicalutamide—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0134	CcSEcCtD
Bicalutamide—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0132	CcSEcCtD
Bicalutamide—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0131	CcSEcCtD
Bicalutamide—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0129	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0129	CcSEcCtD
Bicalutamide—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0129	CcSEcCtD
Bicalutamide—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0126	CcSEcCtD
Bicalutamide—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0126	CcSEcCtD
Bicalutamide—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0123	CcSEcCtD
Bicalutamide—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0118	CcSEcCtD
Bicalutamide—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0118	CcSEcCtD
Bicalutamide—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0116	CcSEcCtD
Bicalutamide—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0116	CcSEcCtD
Bicalutamide—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0115	CcSEcCtD
Bicalutamide—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0114	CcSEcCtD
Bicalutamide—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0113	CcSEcCtD
Bicalutamide—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00986	0.0111	CcSEcCtD
Bicalutamide—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00981	0.011	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00981	0.011	CcSEcCtD
Bicalutamide—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00975	0.011	CcSEcCtD
Bicalutamide—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00972	0.0109	CcSEcCtD
Bicalutamide—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00972	0.0109	CcSEcCtD
Bicalutamide—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00959	0.0108	CcSEcCtD
Bicalutamide—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00954	0.0107	CcSEcCtD
Bicalutamide—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00944	0.0106	CcSEcCtD
Bicalutamide—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00939	0.0105	CcSEcCtD
Bicalutamide—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00914	0.0103	CcSEcCtD
Bicalutamide—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.009	0.0101	CcSEcCtD
Bicalutamide—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00891	0.01	CcSEcCtD
Bicalutamide—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00885	0.00994	CcSEcCtD
Bicalutamide—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00865	0.00973	CcSEcCtD
Bicalutamide—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00802	0.00902	CcSEcCtD
Bicalutamide—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00794	0.00892	CcSEcCtD
Bicalutamide—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0077	0.00866	CcSEcCtD
Bicalutamide—Tension—Hydrochlorothiazide—nephrolithiasis	0.00767	0.00862	CcSEcCtD
Bicalutamide—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00759	0.00853	CcSEcCtD
Bicalutamide—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00756	0.0085	CcSEcCtD
Bicalutamide—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00752	0.00845	CcSEcCtD
Bicalutamide—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00723	0.00812	CcSEcCtD
Bicalutamide—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00714	0.00803	CcSEcCtD
Bicalutamide—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00701	0.00788	CcSEcCtD
Bicalutamide—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00687	0.00772	CcSEcCtD
Bicalutamide—Cough—Hydrochlorothiazide—nephrolithiasis	0.00682	0.00767	CcSEcCtD
Bicalutamide—AR—renal system—nephrolithiasis	0.0068	0.0617	CbGeAlD
Bicalutamide—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00666	0.00748	CcSEcCtD
Bicalutamide—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00666	0.00748	CcSEcCtD
Bicalutamide—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00663	0.00745	CcSEcCtD
Bicalutamide—AR—kidney—nephrolithiasis	0.00657	0.0596	CbGeAlD
Bicalutamide—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00651	0.00732	CcSEcCtD
Bicalutamide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00643	0.00723	CcSEcCtD
Bicalutamide—AR—cortex of kidney—nephrolithiasis	0.0064	0.0581	CbGeAlD
Bicalutamide—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00638	0.00717	CcSEcCtD
Bicalutamide—Shock—Hydrochlorothiazide—nephrolithiasis	0.00628	0.00705	CcSEcCtD
Bicalutamide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00625	0.00702	CcSEcCtD
Bicalutamide—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00617	0.00693	CcSEcCtD
Bicalutamide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00608	0.00683	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00581	0.00653	CcSEcCtD
Bicalutamide—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00649	CcSEcCtD
Bicalutamide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00644	CcSEcCtD
Bicalutamide—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00569	0.00639	CcSEcCtD
Bicalutamide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00567	0.00637	CcSEcCtD
Bicalutamide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00631	CcSEcCtD
Bicalutamide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00555	0.00623	CcSEcCtD
Bicalutamide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0055	0.00618	CcSEcCtD
Bicalutamide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00546	0.00613	CcSEcCtD
Bicalutamide—Pain—Hydrochlorothiazide—nephrolithiasis	0.00546	0.00613	CcSEcCtD
Bicalutamide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00526	0.00591	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00586	CcSEcCtD
Bicalutamide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00507	0.0057	CcSEcCtD
Bicalutamide—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00504	0.00567	CcSEcCtD
Bicalutamide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00504	0.00567	CcSEcCtD
Bicalutamide—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00528	CcSEcCtD
Bicalutamide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00458	0.00514	CcSEcCtD
Bicalutamide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00451	0.00507	CcSEcCtD
Bicalutamide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00437	0.00491	CcSEcCtD
Bicalutamide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00422	0.00474	CcSEcCtD
Bicalutamide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00456	CcSEcCtD
Bicalutamide—Rash—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00452	CcSEcCtD
Bicalutamide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00452	CcSEcCtD
Bicalutamide—Headache—Hydrochlorothiazide—nephrolithiasis	0.004	0.00449	CcSEcCtD
Bicalutamide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00426	CcSEcCtD
Bicalutamide—CYP3A4—renal system—nephrolithiasis	0.00372	0.0338	CbGeAlD
Bicalutamide—CYP2D6—renal system—nephrolithiasis	0.00366	0.0332	CbGeAlD
Bicalutamide—CYP3A4—kidney—nephrolithiasis	0.0036	0.0327	CbGeAlD
Bicalutamide—CYP2D6—kidney—nephrolithiasis	0.00354	0.0321	CbGeAlD
